Tid1 is the human counterpart of the Drosophila tumor suppressor Tid56. Tid56 null mutation causes tumorous imaginal discs resulting from continuous cell proliferation without differentiation. To date, the mechanism of tumor suppression of Tid56 in Drosophila, as well as the cellular function of Tid1 in human tumorigenesis, are poorly understood. By yeast two-hybrid screening, we found that Tid1 interacts with the signaling domain of ErbB2/Her2. Subsequent studies demonstrated that increased expression of Tid1 protein in ErbB2-overexpressing breast cancer cells facilitated the ErbB2 ubiquitination/degradation, as well as caused growth inhibition of these cells. Moreover, by depleting the physiological levels of Tid1 in breast cancer cells using the technique of RNA interference (RNAi), we discovered that the metastatic potential of Tid1-depleted cells was substantially enhanced, resulting from the increased production of interleukin-8 (IL-8) through upregulation of NF-kB activity in the Tid1-knockdown cells. Thus, since Tid1 attenuates signals generated from the ErbB2 receptor as well as negatively regulates the activity of NF-kB, we hypothesize that Tid1, like its Drosophila counterpart, may be an important tumor suppressor, especially in breast carcinogenesis and metastasis. To evaluate this hypothesis in an animal model, we have established a conditional knockout (CKO) animal in which the Tid1 gene can be deleted specifically in mammary epithelial cells. Herein we propose to investigate and evaluate the mechanistic role of Tid1 as a tumor suppressor in regulating tumorigenesis and metastasis of breast cancer not only at the molecular and cellular levels but also in an organismal context.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Tumor Cell Biology Study Section (TCB)
Program Officer
Ault, Grace S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Scripps Research Institute
La Jolla
United States
Zip Code
Deng, Xianming; Elkins, Jonathan M; Zhang, Jinwei et al. (2013) Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones. Eur J Med Chem 70:758-67
Yang, Q; Liao, L; Deng, X et al. (2013) BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction. Oncogene 32:3156-64
Chen, Runqiang; Yang, Qingkai; Lee, Jiing-Dwan (2012) BMK1 kinase suppresses epithelial-mesenchymal transition through the Akt/GSK3ýý signaling pathway. Cancer Res 72:1579-87
Yang, Qingkai; Lee, Jiing-Dwan (2011) Targeting the BMK1 MAP kinase pathway in cancer therapy. Clin Cancer Res 17:3527-32
Deng, Xianming; Dzamko, Nicolas; Prescott, Alan et al. (2011) Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2. Nat Chem Biol 7:203-5
Yang, Qingkai; Deng, Xianming; Lu, Bingwen et al. (2010) Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein. Cancer Cell 18:258-67
Chen, Run-Qiang; Yang, Qing-Kai; Chen, Yan-Ling et al. (2009) Kinome siRNA screen identifies SMG-1 as a negative regulator of hypoxia-inducible factor-1alpha in hypoxia. J Biol Chem 284:16752-8
Chen, Run-Qiang; Yang, Qing-Kai; Lu, Bing-Wen et al. (2009) CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res 69:2663-8
Chen, Yanling; Lu, Bingwen; Yang, Qingkai et al. (2009) Combined integrin phosphoproteomic analyses and small interfering RNA--based functional screening identify key regulators for cancer cell adhesion and migration. Cancer Res 69:3713-20
Zhu, J-H; Chen, R; Yi, W et al. (2008) Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling. Oncogene 27:2525-31